Kangerjia Medical

Company Deals

Triastek Partners with Kangerjia to Develop 3D-Printed Modified Drugs for Sleep Disorders

Fineline Cube Jan 9, 2024

Triastek Inc., a China-based pharmaceutical-focused 3D printing company, has entered into a partnership with fellow...

Company Drug

TransThera Sciences Secures NMPA Conditional Approval for Tinengotinib in Advanced Cholangiocarcinoma with FGFR2 Alterations

Others

Merck Secures FDA Acceptance for Enflonsia sBLA to Expand RSV Prevention Through Second Season in High-Risk Children

Company

Gilead Sciences Reports Q2 2026 Revenue of $7.8B, Driven by HIV Franchise and Trodelvy Growth Despite Cell Therapy Decline

Company

Astellas Reports Record Q1 FY2026 Revenue of ¥640.9B, Driven by Strategic Brands Growth and Raises Full-Year Outlook